hil-214
Vaccineexperimental
Clinical trial activity
4 trials · 1 clinical orgs · 0 marketing orgs
Phase 1
1
Phase 2
1
Phase 3
2
Phase 4
0
Earliest trial started Mar 16, 2022 (NCT05281094)
Timeline
Indications
Studied for
Mechanism of action
- NorovirusImmunity, active
immunity, active - norovirus
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT06007781 | Phase 1 | Aug 18, 2023 | HilleVax |
| NCT05972733 | Phase 2 | Aug 2, 2023 | HilleVax |
| NCT05836012 | Phase 2/Phase 3 (Phase 3) | Jun 2, 2023 | HilleVax |
| NCT05281094 | Phase 2/Phase 3 (Phase 3) | Mar 16, 2022 | HilleVax |
Showing 4 of 4 trials
Page 1 / 1
Organizations
Research & Development (1)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| HilleVax | For profit | 4 | 4 | 3 | 2022 |
1 organizations
Page 1 / 1